Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04720625 · ClinicalTrials.gov registry record · NA

Adapt2Quit - An Adaptive Motivational System for Socio-Economically Disadvantaged Smokers

A NA study, sponsored by University of Massachusetts, Worcester.

Completed
Registry status
NA
Development phase
757
Enrollment target

NCT04720625 is a NA study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 757 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04720625, a NA study, has completed, sponsored by University of Massachusetts, Worcester.

COMPLETED
Registry status
NA
Development phase
757 participants
Enrollment target

Study Summary

The goal of this research is to test the Adapt2Quit computer program that uses participant input (message rating on how much the text motivational message might influence one to quit smoking) to select and text motivational messages that are more likely to help a user stop smoking. This Adapt2Quit system will be compared with a quitline facilitation-only control (text messages will be sent to facilitate quitline use). The primary research hypothesis is that the Adapt2Quit recommender-selected messages will be more effective than a texting quitline facilitation-only control for smoking cessation among socioeconomically disadvantaged (SED) smokers.

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Adapt2Quit

Trial Details

FieldValue
Enrollment Target 757 participants
Start Date 2021-06-28
Est. Completion 2025-03-31
Phase NA

What the Registry Record Tells You About NCT04720625

The ClinicalTrials.gov registry entry for NCT04720625 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 757 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.

NCT04720625 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04720625 about?

NCT04720625 is a clinical study titled "Adapt2Quit - An Adaptive Motivational System for Socio-Economically Disadvantaged Smokers". The goal of this research is to test the Adapt2Quit computer program that uses participant input (message rating on how much the text motivational message might influence one to quit smoking) to select and text motivational messages that are more likely to help a user stop smoking. This Adapt2Quit s...

What is the current status of trial NCT04720625?

This trial is currently completed. It is a NA study. The enrollment target is 757 participants. The study started on 2021-06-28. Estimated completion is 2025-03-31.

What interventions are being tested in trial NCT04720625?

The interventions under investigation include: Control (BEHAVIORAL), Adapt2Quit (BEHAVIORAL).

Who is sponsoring clinical trial NCT04720625?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.